378 related articles for article (PubMed ID: 8561506)
41. Interaction of cytochrome P-450 with hydrocarbons.
Sípal Z; Anzenbacher P; Putz Z; Chlumský J; Krivanová O
Acta Biol Med Ger; 1979; 38(2-3):483-94. PubMed ID: 517011
[TBL] [Abstract][Full Text] [Related]
42. Ropivacaine, a new amide-type local anesthetic agent, is metabolized by cytochromes P450 1A and 3A in human liver microsomes.
Ekström G; Gunnarsson UB
Drug Metab Dispos; 1996 Sep; 24(9):955-61. PubMed ID: 8886604
[TBL] [Abstract][Full Text] [Related]
43. Modulation of cytochrome P-450 induction by long-term food restriction in male rats.
Sohn HO; Lim HB; Lee YG; Lee DW; Lee KB
Biochem Mol Biol Int; 1994 Apr; 32(5):889-96. PubMed ID: 8069238
[TBL] [Abstract][Full Text] [Related]
44. Site of action of substrates requiring cytochrome b5 for oxidation by cytochrome P450.
Waskell LA; Vigne JL; Vergeres G
Methods Enzymol; 1991; 206():523-9. PubMed ID: 1784238
[No Abstract] [Full Text] [Related]
45. Observation of structural variation and spin state conversion of cytochrome P450 CYP2B4 on binding of sterically different substrates.
Macdonald ID; Smith GC; Wolf CR; Smith WE
Biochem Biophys Res Commun; 1996 Sep; 226(1):51-8. PubMed ID: 8806591
[TBL] [Abstract][Full Text] [Related]
46. Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
Ueng YF; Kuwabara T; Chun YJ; Guengerich FP
Biochemistry; 1997 Jan; 36(2):370-81. PubMed ID: 9003190
[TBL] [Abstract][Full Text] [Related]
47. [The role of the hydrophobic fragment of cytochrome b5 in the interaction with cytochrome P-450].
Usanov SA; Bendzko P; Pfeil W; Jänig GR; Ruckpaul K
Bioorg Khim; 1983 Apr; 9(4):450-61. PubMed ID: 6679774
[TBL] [Abstract][Full Text] [Related]
48. Cumene hydroperoxide-supported demethylation reactions catalyzed by cytochrome P450 2B4 lacking the NH2-terminal sequence.
Zhang Y; Pernecky SJ
Biochem Biophys Res Commun; 1999 Apr; 258(1):32-8. PubMed ID: 10222230
[TBL] [Abstract][Full Text] [Related]
49. Interactions of peroxyquinols with cytochromes P450 2B1, 3A1, and 3A5: influence of the apoprotein on heterolytic versus homolytic O-O bond cleavage.
Correia MA; Yao K; Allentoff AJ; Wrighton SA; Thompson JA
Arch Biochem Biophys; 1995 Mar; 317(2):471-8. PubMed ID: 7893165
[TBL] [Abstract][Full Text] [Related]
50. Bromobenzene metabolism in the rabbit: specific forms of cytochrome P-450 involved in 2,3- and 3,4-epoxidation.
Lau SS; Zannoni VG
Mol Pharmacol; 1981 Jul; 20(1):234-5. PubMed ID: 7290087
[No Abstract] [Full Text] [Related]
51. Functional interactions between cytochromes P450 1A2 and 2B4 require both enzymes to reside in the same phospholipid vesicle: evidence for physical complex formation.
Reed JR; Eyer M; Backes WL
J Biol Chem; 2010 Mar; 285(12):8942-52. PubMed ID: 20071338
[TBL] [Abstract][Full Text] [Related]
52. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
Bornheim LM; Franklin MR
Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
[TBL] [Abstract][Full Text] [Related]
53. Interaction of sulfaphenazole derivatives with human liver cytochromes P450 2C: molecular origin of the specific inhibitory effects of sulfaphenazole on CYP 2C9 and consequences for the substrate binding site topology of CYP 2C9.
Mancy A; Dijols S; Poli S; Guengerich P; Mansuy D
Biochemistry; 1996 Dec; 35(50):16205-12. PubMed ID: 8973193
[TBL] [Abstract][Full Text] [Related]
54. Aztreonam decreases hepatic microsomal cytochrome P450 in cynomolgus monkeys.
Ohmori S; Horie T; Hayashi S; Kitada M
Pharmacology; 1994 Mar; 48(3):137-42. PubMed ID: 8153141
[TBL] [Abstract][Full Text] [Related]
55. Residue 285 in cytochrome P450 2B4 lacking the NH(2)-terminal hydrophobic sequence has a role in the functional association of NADPH-cytochrome P450 reductase.
Schulze J; Tschöp K; Lehnerer M; Hlavica P
Biochem Biophys Res Commun; 2000 Apr; 270(3):777-81. PubMed ID: 10772901
[TBL] [Abstract][Full Text] [Related]
56. Influence of mutation of the amino-terminal signal anchor sequence of cytochrome P450 2B4 on the enzyme structure and electron transfer processes.
Lehnerer M; Schulze J; Pernecky SJ; Lewis DF; Eulitz M; Hlavica P
J Biochem; 1998 Aug; 124(2):396-403. PubMed ID: 9685732
[TBL] [Abstract][Full Text] [Related]
57. Construction of a 3D model of cytochrome P450 2B4.
Chang YT; Stiffelman OB; Vakser IA; Loew GH; Bridges A; Waskell L
Protein Eng; 1997 Feb; 10(2):119-29. PubMed ID: 9089811
[TBL] [Abstract][Full Text] [Related]
58. Evidence of binary complex formations between cytochrome P-450, cytochrome b5, and NADPH-cytochrome P-450 reductase of hepatic microsomes.
Tamburini PP; MacFarquhar S; Schenkman JB
Biochem Biophys Res Commun; 1986 Jan; 134(2):519-26. PubMed ID: 3080992
[TBL] [Abstract][Full Text] [Related]
59. Isoflurane: a comparison of its metabolism by human and rat hepatic cytochrome P-450.
Bradshaw JJ; Ivanetich KM
Anesth Analg; 1984 Sep; 63(9):805-13. PubMed ID: 6465574
[TBL] [Abstract][Full Text] [Related]
60. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance.
Zeldin DC; Plitman JD; Kobayashi J; Miller RF; Snapper JR; Falck JR; Szarek JL; Philpot RM; Capdevila JH
J Clin Invest; 1995 May; 95(5):2150-60. PubMed ID: 7738183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
